NCT03425539: An ongoing trial by Idorsia Pharmaceuticals Ltd.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 3 months, 1 week ago.
Full data
Full entry on ClinicalTrials.gov | NCT03425539 |
---|---|
Title | A Multicenter, dOuble-blind, ranDomized, Placebo-controlled, Parallel-group Study to Determine the effIcacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With FabrY Disease |
Results Status | Ongoing |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | June 21, 2018 |
Completion date | Aug. 17, 2021 |
Required reporting date | Aug. 17, 2024, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |